Insiders Revolution Medicines, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 09:14:27 09/05/2024 pm IST			5-day change	1st Jan Change
37.45 ^USD	-2.24%		-2.97%	+32.58%

01:29pm	Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating	MT
08/05	Revolution Medicines Q1 Net Loss Narrows	MT

Revolution Medicines Insider Sold Shares Worth $805,652, According to a Recent SEC Filing	14/03	MT
Revolution Medicines Insider Sold Shares Worth $387,884, According to a Recent SEC Filing	05/01	MT
Revolution Medicines Insider Sold Shares Worth $966,996, According to a Recent SEC Filing	30/12	MT
Revolution Medicines Insider Sold Shares Worth $125,000, According to a Recent SEC Filing	09/12	MT
Revolution Medicines, Inc. Appoints Sandra J. Horning, M.D., as Member of the Board	09/11	CI
Revolution Medicines Insider Sold Shares Worth $848,806, According to a Recent SEC Filing	19/23/19	MT
Revolution Medicines Insider Sold Shares Worth $484,130, According to a Recent SEC Filing	14/23/14	MT
Revolution Medicines Insider Sold Shares Worth $252,175, According to a Recent SEC Filing	21/23/21	MT
Revolution Medicines Insider Sold Shares Worth $239,123, According to a Recent SEC Filing	20/23/20	MT
Insider Sell: Revolution Medicines	07/23/07	MT
Revolution Medicines, Inc. Resigns Eric T. Schmidt as Board of Directors	06/23/06	CI
Insider Sell: Revolution Medicines	02/23/02	MT
Insider Sell: Revolution Medicines	18/23/18	MT
Insider Sell: Revolution Medicines	04/23/04	MT
Revolution Medicines, Inc. Announces Executives Appointment	09/23/09	CI
Insider Buy: Revolution Medicines	13/23/13	MT
Insider Sell: Revolution Medicines	03/22/03	MT
Insider Sell: Revolution Medicines	29/22/29	MT
Revolution Medicines Appoints Jack Anders CFO, Daniel Simon Chief Business Officer	02/22/02	MT
Revolution Medicines, Inc. Announces Executive Changes	02/22/02	CI

No results for this search